Journal of Clinical Pediatrics ›› 2024, Vol. 42 ›› Issue (2): 116-120.doi: 10.12372/jcp.2024.22e0958
Previous Articles Next Articles
ZHOU Yang, WU Yali, DING Yan()
Received:
2022-07-13
Published:
2024-02-15
Online:
2024-02-02
ZHOU Yang, WU Yali, DING Yan. Clinical characteristics and genotype analysis of adenosine deaminase 2 (ADA2) deficiency in China: a report of three cases[J].Journal of Clinical Pediatrics, 2024, 42(2): 116-120.
[1] |
Pinto B, Deo P, Sharma S, et al. Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment[J]. Clin Rheumatol, 2021, 40(10): 3883-3896.
doi: 10.1007/s10067-021-05711-w pmid: 33791889 |
[2] |
Zhou Q, Yang D, Ombrello AK, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2[J]. N Engl J Med, 2014, 370(10): 911-920.
doi: 10.1056/NEJMoa1307361 |
[3] |
Zhang B, Sun Y, Xu N, et al. Adult-onset deficiency of adenosine deaminase 2—a case report and literature review[J]. Clinical Rheumatology, 2021, 40(10): 4325-4339.
doi: 10.1007/s10067-021-05587-w |
[4] | 张冰清, 张硕, 王涛, 等. 第544例结节红斑—血小板减少—青斑样血管病—免疫缺陷[J]. 中华医学杂志, 2021, 101(31): 2485-2487. |
[5] | 柏翠, 郭兴青, 高婷婷, 等. 儿童腺苷脱氨酶2缺乏症2例并文献复习[J]. 中华实用儿科临床杂志, 2020, 35(21): 1674-1677. |
[6] |
Human A, Pagnoux C. Diagnosis and management of ADA2 deficient polyarteritis nodosa[J]. Int J Rheum Dis, 2019, 22 (Suppl 1): 69-77.
doi: 10.1111/apl.2019.22.issue-S1 |
[7] |
Fayand A, Chasset F, Boutboul D, et al. DADA2 diagnosed in adulthood versus childhood: A comparative study on 306 patients including a systematic literature review and 12 French cases[J]. Semin Arthritis Rheum, 2021, 51(6): 1170-1179.
doi: 10.1016/j.semarthrit.2021.09.001 |
[8] |
Meyts I, Aksentijevich I. Deficiency of Adenosine Deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment[J]. J Clin Immunol, 2018, 38(5): 569-578.
doi: 10.1007/s10875-018-0525-8 pmid: 29951947 |
[9] |
Caorsi R, Penco F, Grossi A, et al. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study[J]. Ann Rheum Dis, 2017, 76(10): 1648-1656.
doi: 10.1136/annrheumdis-2016-210802 pmid: 28522451 |
[10] |
Caratsch L, Schnider C, Moi L, et al. Adenosine deaminase 2 deficiency: a disease with multiple presentations[J]. Rev Med Suisse, 2022, 18(776): 669-673.
doi: 10.53738/REVMED.2022.18.776.669 pmid: 35385618 |
[11] |
Sharma A, Naidu G, Sharma V, et al. Deficiency of adenosine deaminase 2 in adults and children: experience from India[J]. Arthritis Rheumatol, 2021, 73(2): 276-285.
doi: 10.1002/art.v73.2 |
[12] |
Nanthapisal S, Murphy C, Omoyinmi E, et al. Deficiency of adenosine deaminase type 2: a description of phenotype and genotype in fifteen cases[J]. Arthritis Rheumatol, 2016, 68(9): 2314-2322.
doi: 10.1002/art.v68.9 |
[13] |
Van Nieuwenhove E, Humblet-Baron S, Van Eyck L, et al. ADA2 deficiency mimicking idiopathic multicentric castleman disease[J]. Pediatrics, 2018, 142(3): e20172266.
doi: 10.1542/peds.2017-2266 |
[14] |
Van Montfrans JM, Hartman EA, Braun KP, et al. Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations[J]. Rheumatology (Oxford), 2016, 55(5): 902-910.
doi: 10.1093/rheumatology/kev439 pmid: 26867732 |
[15] |
Westendorp WF, Nederkoorn PJ, Aksentijevich I, et al. Unexplained early-onset lacunar stroke and inflammatory skin lesions: Consider ADA2 deficiency[J]. Neurology, 2015, 84(20): 2092-2093.
doi: 10.1212/WNL.0000000000001581 pmid: 25888558 |
[16] |
Batu ED, Karadag O, Taskiran EZ, et al. A case series of adenosine deaminase 2-deficient patients emphasizing treatment and genotype-phenotype correlations[J]. J Rheumatol, 2015, 42(8): 1532-1534.
doi: 10.3899/jrheum.150024 pmid: 26233953 |
[17] |
Uettwiller F, Sarrabay G, Rodero MP, et al. ADA2 deficiency: case report of a new phenotype and novel mutation in two sisters[J]. RMD Open, 2016, 2(1): e000236.
doi: 10.1136/rmdopen-2015-000236 |
[18] |
Schena F, Penco F, Volpi S, et al. Dysregulation in B-cell responses and T follicular helper cell function in ADA2 deficiency patients[J]. Eur J Immunol, 2021, 51(1): 206-219.
doi: 10.1002/eji.v51.1 |
[19] |
Lee PY, Kellner ES, Huang Y, et al. Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2)[J]. J Allergy Clin Immunol, 2020, 145(6): 1664-1672.
doi: S0091-6749(20)30030-0 pmid: 31945408 |
[20] |
Özen S, Batu ED, Taşkıran EZ, et al. A monogenic disease with a variety of phenotypes: deficiency of adenosine deaminase 2[J]. J Rheumatol, 2020, 47(1): 117-125.
doi: 10.3899/jrheum.181384 pmid: 31043544 |
[21] |
Navon Elkan P, Pierce SB, Segel R, et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy[J]. N Engl J Med, 2014, 370(10): 921-931.
doi: 10.1056/NEJMoa1307362 |
[22] |
Van Eyck L Jr., Hershfield MS, Pombal D, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency[J]. J Allergy Clin Immunol, 2015, 135(1): 283-287.
doi: 10.1016/j.jaci.2014.10.010 pmid: 25457153 |
[23] |
Garg N, Kasapcopur O, Foster J, 2nd, et al. Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy[J]. Eur J Pediatr, 2014, 173(6): 827-830.
doi: 10.1007/s00431-014-2320-8 pmid: 24737293 |
[24] | 郭莉, 卢美萍. 腺苷脱氨酶2缺乏症研究进展[J]. 中华儿科杂志, 2020, 58(6): 520-523. |
[25] |
Zhang B, Xu N, Chen J, et al. Treatment and outcome in deficiency of adenosine deaminase 2: a literature review[J]. J Investig Allergol Clin Immunol, 2021, 32(1): 13-22.
doi: 10.18176/jiaci |
[26] |
Ombrello AK, Qin J, Hoffmann PM, et al. Treatment strategies for deficiency of adenosine deaminase 2[J]. The New England journal of medicine, 2019, 380(16): 1582-1584.
doi: 10.1056/NEJMc1801927 pmid: 30995379 |
[27] |
Gibson KM, Morishita KA, Dancey P, et al. Identification of novel adenosine deaminase 2 gene variants and varied clinical phenotype in pediatric vasculitis[J]. Arthritis Rheumatol, 2019, 71(10): 1747-1755.
doi: 10.1002/art.v71.10 |
[28] |
Lee PY. Vasculopathy, Immunodeficiency, and bone marrow failure: the intriguing syndrome caused by deficiency of adenosine deaminase 2[J]. Front Pediatr, 2018, 6: 282.
doi: 10.3389/fped.2018.00282 |
[1] | LUO Mingjing, YU Jiaming, WANG Xiaodong, ZHANG Xiaoling, YU Yue, ZHANG Yu, WEN Feiqiu, LIU Sixi. Clinical analysis of invasive fungal disease secondary to allogeneic hematopoietic stem cell transplantation in 424 children with thalassemia [J]. Journal of Clinical Pediatrics, 2025, 43(1): 21-28. |
[2] | LIU Dongxia, JIN Rong, LIN Rongjun. Risk factors analysis of severe refractory Mycoplasma pneumoniae pneumonia complicated with bronchitis obliterans in children [J]. Journal of Clinical Pediatrics, 2025, 43(1): 29-34. |
[3] | ZHONG Jinhong, WANG Can, CHEN Fang. Progress in the research of infantile fiberoptic bronchoscopy sedation [J]. Journal of Clinical Pediatrics, 2025, 43(1): 50-55. |
[4] | JIANG Weiqin, WANG Jing, CHENG Anna, CHEN Tingting, HUANG Yujuan. Predictors of recurrent febrile seizures during the same febrile illness in children with febrile seizures [J]. Journal of Clinical Pediatrics, 2025, 43(1): 8-13. |
[5] | QIU Xiu, WEI Dongmei, LIN Shanshan, XIA Huimin, ZHOU Wenhao. Principles and practice of the Born in Guangzhou Cohort Study [J]. Journal of Clinical Pediatrics, 2024, 42(9): 747-752. |
[6] | FAN Jianxia. The origins and development of the healthy life trajectory program: a cohort of community-family-mother-child multidimensional interventions for overweight and obesity in children [J]. Journal of Clinical Pediatrics, 2024, 42(9): 768-773. |
[7] | JIANG Tao, LI Shuangjie, TANG Lian, OUYANG Wenxian. Immunobiological properties of peripheral blood MAIT cells in children with chronic hepatitis B [J]. Journal of Clinical Pediatrics, 2024, 42(9): 787-790. |
[8] | ZHOU Jie, LIU Keqiang, WANG Jinling, WANG Ying. Megacystis-microcolon-intestinal hypoperistalsis syndrome caused by MYH11 elongating mutation : a case report and literatures review [J]. Journal of Clinical Pediatrics, 2024, 42(9): 798-804. |
[9] | CHU Sijia, TANG Jihong. Research progress of central nervous system injury associated with pediatric acute lymphoblastic leukemia and its treatment [J]. Journal of Clinical Pediatrics, 2024, 42(9): 811-816. |
[10] | DING Yaping, XIA Shanshan, ZHANG Chenmei. Interpretation of “2023 Children’s Renal Nutrition Working Group Clinical Practice Recommendations: Nutritional Management of Children with Acute Kidney Injury” [J]. Journal of Clinical Pediatrics, 2024, 42(8): 667-672. |
[11] | LI Yirong, LI Huiping, GAO Jingyu, XIAO Yuhua, CHEN Xiaomin, LU Yanling, ZHAO Nana, FENG Xiaoqin. Comparison of different doses of cytarabine for induction chemotherapy in children with acute myeloid leukemia in FLAG-IDA regimen [J]. Journal of Clinical Pediatrics, 2024, 42(8): 673-677. |
[12] | HUANG Bo, DONG Yanying, SONG Linlan. Clinical characteristics of 348 children with infectious mononucleosis [J]. Journal of Clinical Pediatrics, 2024, 42(8): 678-683. |
[13] | WANG Dan, SHAO Jingbo, LI Hong, ZHANG Na, ZHU Jiashi, FU Pan, WANG Zhen. Clinical analysis of 38 cases of hematological malignancies complicated with tumor lysis syndrome in children [J]. Journal of Clinical Pediatrics, 2024, 42(8): 684-690. |
[14] | MA Yan, WEI Xingjiao, BAI Hua, ZHANG Yan, TIAN Xinmin, Aqsa Ahmad, LIANG Lijun. Analysis of etiological composition and clinical features of stage 5 chronic kidney disease in children in a tertiary hospital in western China [J]. Journal of Clinical Pediatrics, 2024, 42(8): 697-703. |
[15] | WANG Ye, ZHANG Linlin, CHI Zuofei, SUN Ruowen, JIANG Zehui, XU Gang. A case of clinical report of T-lymphoblastic lymphoma secondary to acute promyelocytic leukemia in children [J]. Journal of Clinical Pediatrics, 2024, 42(8): 722-727. |
|